Robin Monotti
66.9K subscribers
15.7K photos
8.73K videos
625 files
30.1K links
Official Robin Monotti Channel
Donations:
robinmonotti.substack.com/
Group is @robinmggroup
We don't DM from this channel account.
Rule: Be polite & respectful.
Download Telegram
4_5981326431714543436.pdf
819.8 KB
4_5981326431714543436.pdf
Forwarded from James Delingpole Channel
My personal highlight of Saturday was meeting Lozza's dad James Fox. He gave up being an acting legend in the 60s to find God. He was about half a century ahead of us. James's advice to Lozza is: "If you're going to take on a struggle of this magnitude you're going to need spiritual support." I believe he's totally right. 'God is our hope and strength, a very present help in trouble,' as one of the Psalms I used to croak very reluctantly at my Colditz-like prep school used to put it. Turns out the psalm was right and all that Christian grounding wasn't wasted after all.
India in perspective.
India in context of human manure spreading season
Forwarded from Snor
Those pictures of funeral pyres in India are common place. Tourists even pay $10 each to go and watch!
I was in the himalayas in 2013 when the monsoon season started early and thousands of people were killed in the flooding. Rescue helicopters came loaded with timber that was used to build huge pyres for the dead, before rescuing the survivors.
The images being used by the media are purely for shock and fear value, I wouldn't be surprised if they are even library images of old funerals.
FACE MASKS AS THE PORTABLE VERSION OF SICK BUILDING SYNDROME or SBS.
"The fact that prolonged exposure to latently elevated CO2 levels and
unfavorable breathing air compositions has disease-promoting effects
was recognized early on. As early as 1983, the WHO described “Sick
Building Syndrome” (SBS) as a condition in which people living indoors
experienced acute disease-relevant effects that increased with time of
their stay, without specific causes or diseases [161,162]. The syndrome
affects people who spend most of their time indoors, often with
subliminally elevated CO2 levels, and are prone to symptoms such as
increased heart rate, rise in blood pressure, headaches, fatigue and
difficulty concentrating [38,162]. Some of the complaints described in
the mask studies we found (Figure 2) are surprisingly similar to those
of Sick Building Syndrome [161]. Temperature, carbon dioxide content of
the air, headaches, dizziness, drowsiness and itching also play a role
in Sick Building Syndrome. On the one hand, masks could themselves be
responsible for effects such as those described for Sick Building
Syndrome when used for a longer period of time. On the other hand, they
could additionally intensify these effects when worn in air-conditioned
buildings, especially when masks are mandatory indoors. Nevertheless,
there was a tendency towards higher systolic blood pressure values in
mask wearers in some studies [21,31,34], but statistical significance
was only found in two studies [25,35]. However, we found more relevant
and significant evidence of heart rate increase, headache, fatigue and
concentration problems associated with mask wearers (Figure 2)
indicating the clinical relevance of wearing masks."

Kai Kisielinski et al., "Is a Mask That Covers the Mouth and Nose Free
from Undesirable Side Effects in Everyday Use and Free of Potential
Hazards?," International Journal of Environmental Research and Public
Health 18, no. 8 (April 2021), https://doi.org/10.3390/ijerph18084344
India. This is the most worrying graph.
I'll put them down as undecided.. 😉
COVID ANXIETY SYNDROME

"A brief new measure to assess COVID-19 anxiety syndrome features is presented.
•
The measure has acceptable levels of reliability and concurrent validity.
•
The measure was found to predict COVID-19 anxiety and work and social adjustment controlling for other variables."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375349/
India, the graph they forgot. Must have been a careless mistake of course
If you have friends and family in India, send them these:
Forwarded from Robin Monotti
Therapeutic efficacy of macrolides in management of patients with mild COVID-19

Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrahman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud

The overall results revealed significant early improvement of symptoms (fever, dyspnea and cough) in patients treated with either azithromycin or clarithromycin compared to control group, also there was significant early conversion of SARS-CoV-2 PCR to negative in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).There was no significant difference in time to improvement of fever, cough, dyspnea, anosmia, GIT symptoms and time to PCR negative conversion between patients treated with azithromycin compared to patients treated with clarithromycin (p˃0.05 for all). Follow up chest CT done after 2 weeks of start of treatment showed significant improvement in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).Adding Clarithromycin or Azithromycin to the therapeutic protocols for COVID-19 could be beneficial for early control of fever and early PCR negative conversion in Mild COVID-19"

https://www.researchsquare.com/article/rs-181996/v1
From Carlo Brogna's research. Antibiotics which work against bacteria in which SARSCoV2 replicates have -100% written next to them.
https://zenodo.org/record/4088208#.YGRIdk8XadN